Hear.com Horizon Go IX vs JLab Hear OTC

The Hear.com Horizon Go IX is a premium prescription behind-the-ear hearing aid released in 2024, priced at $6,500. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #19 among 39 prescription hearing aids tested. Speech performance is a clear strength for the Horizon Go IX. It scores 4.0/5 in speech-in-quiet conditions—0.64 points above the category average—delivering strong audibility in conversational settings. Speech-in-noise performance also exceeds the category average by 0.46 points, though at 2.6/5 the absolute score remains mixed, meaning challenging listening environments may still pose difficulties. Own-voice comfort is the device's most notable weakness, scoring just 1.8/5—a low result that falls 0.90 points below the category average. Users sensitive to how their own voice sounds may find this limiting. Feedback handling scores 4.4/5, which is strong in absolute terms, though slightly below the category average of 4.72/5. Music streaming performance is essentially average at 2.7/5. At this price point, shoppers face stiff competition. Several alternatives in the same premium tier—including the Phonak Sphere Infinio, Oticon Intent, and Widex Allure RIC 440—deliver higher overall scores. Devices like the Rexton Reach R-Li T80 at Costco offer comparable or better sound performance at lower prices. The Horizon Go IX is best suited for users who prioritize speech clarity and have access to this product through hear.com's network, but those flexible on brand should compare alternatives before committing.

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.